Literature DB >> 21655845

Cost-effectiveness of community health worker versus home-based guardians for directly observed treatment of tuberculosis in Vitória, Espírito Santo State, Brazil.

Thiago Nascimento do Prado1, Nikolas Wada, Leticia Molino Guidoni, Jonathan E Golub, Reynaldo Dietze, Ethel Leonor Noia Maciel.   

Abstract

The objective of this study was to compare the costs and outcomes associated with guardian-supervised directly observed treatment relative to the standard of care Directly Observed Therapy, Short Course (DOTS) provided by community health workers (CHW). New cases of culture-positive pulmonary tuberculosis (TB) treated in Vitória, Espírito Santo State, Brazil, between January 2005 and December 2006 were interviewed and chose their preferred treatment strategy. Costs incurred by providers and patients (and patients' families) were estimated, and cost-effectiveness was assessed by comparing costs per successfully treated patient. 130 patients were included in the study; 84 chose CHW-supervised DOTS and 46 chose guardian-supervised DOTS. 45 of 46 (98%) patients treated with guardian-supervised DOTS were cured or completed treatment compared to 70/84 (83%) of the CHW-supervised patients (p = 0.01). Logistic regression showed only the strategy of supervision to be a significant association with treatment outcome, with guardian-supervised care strongly protective. Cost per patient treated with guardian-supervised DOTS was US$398, compared to US$548 for CHW-supervised DOTS. The guardian-supervised DOTS is an attractive option to complement CHW-supervised DOTS.

Entities:  

Mesh:

Year:  2011        PMID: 21655845      PMCID: PMC3713773          DOI: 10.1590/s0102-311x2011000500012

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  22 in total

1.  Direct observation of tuberculosis treatment by supervised family members in Yasothorn Province, Thailand.

Authors:  S Akkslip; S Rasmithat; D Maher; H Sawert
Journal:  Int J Tuberc Lung Dis       Date:  1999-12       Impact factor: 2.373

2.  Effectiveness of DOT for tuberculosis treatment outcomes: a prospective cohort study in Bangkok, Thailand.

Authors:  K Okanurak; D Kitayaporn; W Wanarangsikul; C Koompong
Journal:  Int J Tuberc Lung Dis       Date:  2007-07       Impact factor: 2.373

3.  Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis.

Authors:  D M Needham; P Godfrey-Faussett; S D Foster
Journal:  Int J Tuberc Lung Dis       Date:  1998-10       Impact factor: 2.373

Review 4.  International standards for tuberculosis care.

Authors:  Philip C Hopewell; Madhukar Pai; Dermot Maher; Mukund Uplekar; Mario C Raviglione
Journal:  Lancet Infect Dis       Date:  2006-11       Impact factor: 25.071

5.  Household members and health care workers as supervisors of tuberculosis treatment.

Authors:  Ethel Leonor Noia Maciel; Leticia Molino Guidoni; Ana Paula Brioshi; Thiago Nascimento do Prado; Geisa Fregona; David Jamil Hadad; Lucilia Pereira Molino; Moises Palaci; John L Johnson; Reynaldo Dietze
Journal:  Rev Saude Publica       Date:  2010-04       Impact factor: 2.106

6.  Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand.

Authors:  P Kamolratanakul; H Sawert; S Lertmaharit; Y Kasetjaroen; S Akksilp; C Tulaporn; K Punnachest; S Na-Songkhla; V Payanandana
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Sep-Oct       Impact factor: 2.184

Review 7.  [Directly observed therapy using home-based supervisors for treating tuberculosis in Vitória, Brazil].

Authors:  Ethel Leonor Noia Maciel; Ana Paula Silva; Waleska Meireles; Karina Fiorotti; David Jamil Hadad; Reynaldo Dietze
Journal:  J Bras Pneumol       Date:  2008-07       Impact factor: 2.624

8.  Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis.

Authors:  M Zwarenstein; J H Schoeman; C Vundule; C J Lombard; M Tatley
Journal:  Lancet       Date:  1998-10-24       Impact factor: 79.321

9.  Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial.

Authors:  James N Newell; Sushil C Baral; Shanta B Pande; Dirgh Sing Bam; Pushpa Malla
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

Review 10.  Directly observed therapy for treating tuberculosis.

Authors:  J Volmink; P Garner
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
View more
  16 in total

Review 1.  Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.

Authors:  Yoko V Laurence; Ulla K Griffiths; Anna Vassall
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

2.  Community based interventions for the prevention and control of tuberculosis.

Authors:  Ahmed Arshad; Rehana A Salam; Zohra S Lassi; Jai K Das; Imama Naqvi; Zulfiqar A Bhutta
Journal:  Infect Dis Poverty       Date:  2014-08-01       Impact factor: 4.520

3.  Valuing the work of unpaid community health workers and exploring the incentives to volunteering in rural Africa.

Authors:  Frida Kasteng; Stella Settumba; Karin Källander; Anna Vassall
Journal:  Health Policy Plan       Date:  2015-05-22       Impact factor: 3.344

4.  Coping with tuberculosis and directly observed treatment: a qualitative study among patients from South India.

Authors:  Vijayashree Yellappa; Pierre Lefèvre; Tullia Battaglioli; Devadasan Narayanan; Patrick Van der Stuyft
Journal:  BMC Health Serv Res       Date:  2016-07-19       Impact factor: 2.655

5.  Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.

Authors:  Brandon A Berger; Alexandra Cossio; Nancy Gore Saravia; Maria Del Mar Castro; Sergio Prada; Allison H Bartlett; Mai T Pho
Journal:  PLoS Negl Trop Dis       Date:  2017-04-06

Review 6.  Does task shifting yield cost savings and improve efficiency for health systems? A systematic review of evidence from low-income and middle-income countries.

Authors:  Gabriel Seidman; Rifat Atun
Journal:  Hum Resour Health       Date:  2017-04-13

7.  Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.

Authors:  C Hutchison; M S Khan; J Yoong; X Lin; R J Coker
Journal:  BMC Public Health       Date:  2017-02-22       Impact factor: 3.295

Review 8.  Costs and cost-effectiveness of community health workers: evidence from a literature review.

Authors:  Kelsey Vaughan; Maryse C Kok; Sophie Witter; Marjolein Dieleman
Journal:  Hum Resour Health       Date:  2015-09-01

Review 9.  Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review.

Authors:  Tadayuki Tanimura; Ernesto Jaramillo; Diana Weil; Mario Raviglione; Knut Lönnroth
Journal:  Eur Respir J       Date:  2014-02-13       Impact factor: 16.671

Review 10.  Impact of Community-Based DOT on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis.

Authors:  HaiYang Zhang; John Ehiri; Huan Yang; Shenglan Tang; Ying Li
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.